Membrane level of omega-3 docosahexaenoic acid is associated with severity of obstructive sleep apnea

Journal of Clinical Sleep Medicine

Volumn 7, Issue 4, 2011, Pages 391-396

  Ladesich, James B ^a   Pottala, James V ^b   Romaker, Ann ^c   Harris, William S ^b,d  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b SANFORD RESEARCH   (United States)

^c Romaker and Associates   (United States)

^d UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Biomarkers; Docosahexaenoic acid; Epidemiology; Omega 3 fatty acids; Sleep disordered breathing

Indexed keywords

ALCOHOL; DOCOSAHEXAENOIC ACID; FISH OIL; OMEGA 3 FATTY ACID;

ADULT; ALCOHOL CONSUMPTION; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; FISH; HUMAN; MAJOR CLINICAL STUDY; MALE; RACE; RISK FACTOR; SLEEP APNEA SYNDROME; SLEEP PATTERN; SMOKING;

ADULT; BIOLOGICAL MARKERS; BLOOD GAS ANALYSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DOCOSAHEXAENOIC ACIDS; ERYTHROCYTE MEMBRANE; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 80051903578     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/JCSM.1198     Document Type: Article

References (52)

1. Gottlieb D.J., Yenokyan G., Newman A.B., et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: The sleep heart health study. Circulation 2010;122:352-360
2. Shamsuzzaman A.S., Winnicki M., Lanfranchi P., et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 2002;105:2462-2464 (Pubitemid 34568964)
3. Nanas S., Sakellariou D., Kapsimalakou S., et al. Heart rate recovery and oxygen kinetics after exercise in obstructive sleep apnea syndrome. Clin Cardiol 2010;33:46-51.
4. Gami A.S., Howard D.E., Olson E.J., Somers V.K. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 2005;352:1206-1214
5. Farzaneh-Far R., Harris W.S., Garg S., Na B., Whooley M.A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009;205:538-543
6. Kelley D.S., Siegel D., Fedor D.M., Adkins Y., Mackey B.E. DHA supplementation decreases serum C-reactive protein and other markers of inflammation in hypertriglyceridemic men. J Nutr 2009;139:495-501.
7. Christensen J.H., Schmidt E.B. Autonomic nervous system, heart rate variability and n-3 fatty acids. J Cardiovasc Med (Hagerstown) 2007;8 Suppl 1:S19-S22. (Pubitemid 47429076)
8. Mozaffarian D., Geelen A., Brouwer I.A., Geleijnse J.M., Zock P.L., Katan M.B. Effect of fish oil on heart rate in humans: A meta-analysis of randomized controlled trials. Circulation 2005;112:1945-1952 (Pubitemid 41377412)
9. Mozaffarian D., Stein P.K., Prineas R.J., Siscovick D.S. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 2008;117:1130-1137 (Pubitemid 351544069)
10. Albert C.M., Campos H., Stampfer M.J., et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 2002;346:1113-1118 (Pubitemid 34984601)
11. Siscovick D.S., Raghunathan T.E., King I., et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995;274:1363-1367
12. Colombo J., Kannass K.N., Shaddy D.J., et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004;75:1254-1267 (Pubitemid 39137766)
13. Hibbeln J.R., Davis J.M., Steer C., et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observational cohort study. Lancet 2007;369:578-585 (Pubitemid 46241443)
14. Birch E.E., Carlson S.E., Hoffman D.R., et al. The DIAMOND (DHA Intake and Measurement of Neural Development) Study: A double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010;91:848-859
15. Helland I.B., Smith L., Saarem K., Saugstad O.D., Drevon C.A. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003;111:e39-e44.
16. Cheruku S.R., Montgomery-Downs H.E., Farkas S.L., Thoman E.B., Lammi-Keefe C.J. Higher maternal plasma docosahexaenoic acid during pregnancy is associated with more mature neonatal sleep-state patterning. Am J Clin Nutr 2002;76:608-613 (Pubitemid 34920839)
17. Holty J.E., Guilleminault C. Maxillomandibular advancement for the treatment of obstructive sleep apnea: A systematic review and meta-analysis. Sleep Med Rev 2010;14:287-297
18. Harris W.S., Pottala J.V., Sands S.A., Jones P.G. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am J Clin Nutr 2007;86:1621-1625 (Pubitemid 350232175)
19. Harris W.S., Von Schacky C. The Omega-3 Index: A new risk factor for death from coronary heart disease? Prev Med 2004;39:212-220 (Pubitemid 38797975)
20. Cleveland W.S. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-836
21. Harris W.S., Mozaffarian D., Lefevre M., et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009;139:804S-819S.
22. Lee J.H., O'Keefe J.H., Lavie C.J., Harris W.S. Omega-3 fatty acids: Cardiovascular benefits, sources and sustainability. Nat Rev Cardiol 2009;6:753-758
23. Sekikawa A., Curb J.D., Ueshima H., et al. Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: A cross-sectional study. J Am Coll Cardiol 2008;52:417-424 (Pubitemid 352043837)
24. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002;105:1897-1903 (Pubitemid 34437615)
25. GISSI-HF investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): A randomised, double-blind, placebocontrolled trial. Lancet 2008;372:1223-1230
26. Yokoyama M., Origasa H., Matsuzaki M., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-1098 (Pubitemid 46483662)
27. Hibbeln J.R., Ferguson T.A., Blasbalg T.L. Omega-3 fatty acid deficiencies in neurodevelopment, aggression and autonomic dysregulation: Opportunities for intervention. Int Rev Psychiatry 2006;18:107-118 (Pubitemid 43791674)
28. Stoll A.L., Severus W.E., Freeman M.P., et al. Omega 3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry 1999;56:407-412 (Pubitemid 29215428)
29. Logan A.C. Omega-3 fatty acids and major depression: A primer for the mental health professional. Lipids Health Dis 2004;3:25-33.
30. Chang P.P., Ford D.E., Mead L.A., Cooper-Patrick L., Klag M.J. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am J Epidemiol 1997;146:105-114 (Pubitemid 27329194)
31. Cricco M., Simonsick E.M., Foley D.J. The impact of insomnia on cognitive functioning in older adults. J Am Geriatr Soc 2001;49:1185-1189 (Pubitemid 32900145)
32. Resnick H.E., Redline S., Shahar E., et al. Diabetes and sleep disturbances: Findings from the Sleep Heart Health Study. Diabetes Care 2003;26:702-709 (Pubitemid 36929331)
33. Akbar M., Calderon F., Wen Z., Kim H.Y. Docosahexaenoic acid: A positive modulator of Akt signaling in neuronal survival. Proc Natl Acad Sci U S A 2005;102:10858-10863 (Pubitemid 41105957)
34. Chen C., Bazan N.G. Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons. J Neurophysiol 2005;93:929-941
35. Harris W.S., Reid K.J., Sands S.A., Spertus J.A. Blood omega-3 and trans Fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007;99:154-158 (Pubitemid 46072748)
36. Block R.C., Harris W.S., Pottala J.V. Determinants of blood cell omega-3 fatty acid content. Open Biomarkers J 2008;1:1-6.
37. Itomura M., Fujioka S., Hamazaki K., et al. Factors influencing EPA+DHA levels in red blood cells in Japan. In Vivo 2008;22:131-135
38. Shah N., Roux F. The relationship of obesity and obstructive sleep apnea. Clin Chest Med 2009;30:455-465, vii.
39. Cazzola R., Rondanelli M., Russo-Volpe S., Ferrari E., Cestaro B. Decreased membrane fluidity and altered susceptibility to peroxidation and lipid composition in overweight and obese female erythrocytes. J Lipid Res 2004;45:1846-1851 (Pubitemid 40990876)
40. Partinen M. Epidemiology of obstructive sleep apnea syndrome. Curr Opin Pulm Med 1995;1:482-487
41. Lavie P., Herer P., Peled R., et al. Mortality in sleep apnea patients: A multivariate analysis of risk factors. Sleep 1995;18:149-157
42. Andreas S., Schulz R., Werner G.S., Kreuzer H. Prevalence of obstructive sleep apnoea in patients with coronary artery disease. Coron Artery Dis 1996;7:541-545 (Pubitemid 26365631)
43. Shahar E., Whitney C.W., Redline S., et al. Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. (Pubitemid 32095247)
44. Peppard P.E., Young T., Palta M., Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384 (Pubitemid 30262394)
45. Quan S.F., Howard B.V., Iber C., et al. The Sleep Heart Health Study: Design, rationale, and methods. Sleep 1997;20:1077-1085 (Pubitemid 28082298)
46. Chin K., Ohi M., Kita H., et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153:1972-1976 (Pubitemid 26187928)
47. Bokinsky G., Miller M., Ault K., Husband P., Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 1995;108:625-630
48. Rangemark C., Hedner J.A., Carlson J.T., Gleerup G., Winther K. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. Sleep 1995;18: 188-94.
49. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983;52:490-494
50. Shepard J.W., Jr., Garrison M.W., Grither D.A., Dolan G.F. Relationship of ventricular ectopy to oxyhemoglobin desaturation in patients with obstructive sleep apnea. Chest 1985;88:335-340 (Pubitemid 15248089)
51. Javaheri S., Parker T.J., Liming J.D., et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998;97:2154-2159 (Pubitemid 28262123)
52. Kanagala R., Murali N.S., Friedman P.A., et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation 2003;107:2589-2594 (Pubitemid 36628941)